Stay updated on Monalizumab Plus Cetuximab Clinical Trial
Sign up to get notified when there's something new on the Monalizumab Plus Cetuximab Clinical Trial page.

Latest updates to the Monalizumab Plus Cetuximab Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe site’s footer revision/version was updated from v3.5.2 to v3.5.3 for this page display.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoChange DetectedReplaced Padua, Italy, 35128 with Padova, Italy, 35128 in the locations list.SummaryDifference0.0%

- Check41 days agoChange DetectedThe location label Napoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the study locations list.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded a concise statement that the study is a randomized, double-blind, multicenter, global Phase 3 trial comparing monalizumab plus cetuximab versus placebo plus cetuximab in recurrent or metastatic head and neck cancer.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.0%

Stay in the know with updates to Monalizumab Plus Cetuximab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Monalizumab Plus Cetuximab Clinical Trial page.